These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6563035)

  • 21. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
    Villar H; Jugo M; Farinati A
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of 50 isolates of Clostridium perfringens to cefotaxime, fosfomycin, penicillin G and vancomycin; variable tolerance for vancomycin.
    Jung WK
    Chemotherapy; 1983; 29(2):99-103. PubMed ID: 6301777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
    Sears SD; Tatem BA; Standiford HC
    Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.
    Mendes RE; Castanheira M; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Glob Antimicrob Resist; 2017 Mar; 8():28-32. PubMed ID: 27939809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in-vitro activity of fourteen antibiotics against clinical isolates of enterococci.
    Abd-Elalim Eltahawy AT; Fouad Khalaf RM
    J Chemother; 1990 Dec; 2(6):351-4. PubMed ID: 2093105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity of penicillin-resistance pneumococci].
    Cullmann W; Schlunegger H
    Immun Infekt; 1993 Feb; 21(1):9-12. PubMed ID: 8330895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
    Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
    Traub WH; Leonhard B
    Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.
    Rosser SJ; Alfa MJ; Hoban S; Kennedy J; Harding GK
    J Clin Microbiol; 1999 Jan; 37(1):26-30. PubMed ID: 9854058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
    Henriques Normark B; Novak R; Ortqvist A; Källenius G; Tuomanen E; Normark S
    Clin Infect Dis; 2001 Feb; 32(4):552-8. PubMed ID: 11181117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 37. Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci.
    Shanson DC; Tadayon M; Bakhtiar M
    J Antimicrob Chemother; 1986 Oct; 18(4):479-90. PubMed ID: 3095305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resistance of nongroupable streptococci to beta-lactams. Detection by antibiogram and the activity of combinations of penicillin G and gentamicin].
    Leclercq R; Besbes S; Soussy CJ
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):626-31. PubMed ID: 3054738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci.
    Thornsberry C; Karlowsky JA; Kelly LJ; Draghi DC; Critchley IA; Jones ME; Sahm DF
    Chemotherapy; 2001; 47(5):332-43. PubMed ID: 11561135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.